Diane Parks joins the TriSalus board with more than 30 years of expertise across the biotech, pharmaceutical, and advertising industries. She’s held executive roles at Kite Pharma Inc, Pharmacyclics, Amgen, and Genentech, most recently serving as senior vice president, marketing and account management at Kite Pharma Inc. Ms. Parks is credited with successfully leading the launch of the first-ever CAR-T therapy, YESCARTA.
She holds a Master of Business Administration degree from Georgia State University and received her Bachelor of Arts degree from Kansas State University. Diane currently serves on several other boards including Calliditas Therapeutics, Kura Oncology, CTI BioPharma and Soligenix, all early-stage biotechnology companies.
